BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 35719999)

  • 1. Association of Tumor Size With Myometrial Invasion, Lymphovascular Space Invasion, Lymph Node Metastasis, and Recurrence in Endometrial Cancer: A Meta-Analysis of 40 Studies With 53,276 Patients.
    Jin X; Shen C; Yang X; Yu Y; Wang J; Che X
    Front Oncol; 2022; 12():881850. PubMed ID: 35719999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Myometrial Invasion With Lymphovascular Space Invasion, Lymph Node Metastasis, Recurrence, and Overall Survival in Endometrial Cancer: A Meta-Analysis of 79 Studies With 68,870 Patients.
    Wang J; Xu P; Yang X; Yu Q; Xu X; Zou G; Zhang X
    Front Oncol; 2021; 11():762329. PubMed ID: 34746002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological and prognostic significance of blood microvessel density in endometrial cancer: a meta-analysis and subgroup analysis.
    Wang JZ; Xiong YJ; Man GCW; Chen XY; Kwong J; Wang CC
    Arch Gynecol Obstet; 2018 Mar; 297(3):731-740. PubMed ID: 29327157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Satellite lymphovascular space invasion: An independent risk factor in early stage cervical cancer.
    Pol FJ; Zusterzeel PL; van Ham MA; Kuijpers DA; Bulten J; Massuger LF
    Gynecol Oncol; 2015 Sep; 138(3):579-84. PubMed ID: 26126782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor affecting lymph node metastasis in uterine papillary serous carcinomas: a retrospective analysis.
    Tutkun Kilinc EC; Korkmaz V; Yalcin HR
    J Obstet Gynaecol; 2022 Nov; 42(8):3725-3730. PubMed ID: 36927276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is microcystic, elongated, and fragmented pattern of myometrial invasion in endometrioid endometrial carcinoma associated with survival?
    Altındağ SD; Yiğit S; Şen S
    Turk J Med Sci; 2022 Oct; 52(5):1569-1579. PubMed ID: 36422476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive Values of Programmed Cell Death-Ligand 1 Expression for Prognosis, Clinicopathological Factors, and Response to Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Inhibitors in Patients With Gynecological Cancers: A Meta-Analysis.
    Front Oncol; ; . PubMed ID: 33634012
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 9.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.